The spatiotemporal regulation of the Ras/ERK pathway is critical in determining the physiological and pathophysiological outcome of signalling. Dual-specificity mitogen-activated protein kinase (MAPK) phosphatases (DUSPs or MKPs) are key regulators of pathway activity and may also localise ERK to distinct subcellular locations. Here we present methods largely based on the use of high content microscopy to both visualise and quantitate the subcellular distribution of activated (p-ERK) and total ERK in populations of mouse embryonic fibroblasts derived from mice lacking DUSP5, a nuclear ERKspecific MKP. Such methods in combination with rescue experiments using adenoviral vectors encoding wild type and mutant forms of DUSP5 have allowed us to visualise specific defects in ERK regulation in these cells thus confirming the role of this phosphatase as both a nuclear regulator of ERK activity and localisation.
Introduction
The core Ras/extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) signalling pathway is comprised of a three-component module in which a member of the Raf family of MAPK kinase kinases (MKKKs or MEKKs) phosphorylates and activates a MAPK kinase (MKK or MEK). The latter is a dual-specificity (Thr/Tyr) protein kinase, which phosphorylates both residues within the conserved T-X-Y activation loop motif to activate ERK1 and ERK2 (1) . This pathway mediates a wide variety of physiological outcomes in response to extracellular stimuli. These include cell proliferation, differentiation, transformation, migration and survival (2) (3) (4) . In addition, Ras/MAPK signalling is frequently deregulated in human cancers, often due to activating mutations in upstream pathway components such as receptor tyrosine kinases (RTKs), the Ras family of small GTPases, the Braf MAPK kinase kinase and MAPK kinases (5) . Thus, Ras/ERK signalling components are a major focus of anticancer drug development with a range of small molecule inhibitors of RTKs, Braf and MEK either in development or clinical use (6, 7) .
The diversity of physiological outputs of Ras/ERK signalling is due to the coordinated phosphorylation of a wide range of cellular ERK substrates. These include transcription factors, protein kinases, metabolic enzymes and cytoskeletal proteins (8, 9) . Clearly, because these substrates either reside in or are associated with distinct subcellular compartments, the spatial as well as the temporal control of Ras/ERK signalling is a critical determinant of biological outcome. This may explain, at least in part, why ERK activation can result in quite different endpoints within the same cell type. A good example of the latter is the ability of nerve growth factor (NGF) to cause sustained activation and nuclear localisation of ERK in rat PC12 cells leading to differentiation and neurite outgrowth, while exposure to epidermal growth factor (EGF) instead results in transient ERK activation and drives cell proliferation (10) .
Exactly how the spatial organisation of the Ras/ERK pathway is regulated is still unclear and likely to be complex. Various mechanisms have been proposed to underpin the growth factor-induced nuclear translocation of ERK itself, including activation-dependent dimerization, active/passive transport and the phosphorylation of additional regulatory sites on ERK that promote its association with importin7 3 (11) . In addition, it is clear that a diverse array of proteins can act as ERK binding partners and retain ERKs in specific subcellular locations. The latter include MKK/MEK, scaffold proteins such as b-arrestin and kinase suppressor of Ras (KSR), phosphoprotein enriched in astrocytes-15 (PEA-15) and cytoskeletal elements such as microtubule and actin filaments (12) . One class of ERK regulatory proteins that clearly plays a role in controlling both the activity and localisation of ERK1 and ERK2 are the dual-specificity MAPK phosphatases (DUSPs or MKPs) exemplified by DUSP5 and DUSP6/MKP-3 (13).
DUSP6/MKP-3 is a cytoplasmic ERK-specific MKP that binds tightly to the common docking (CD) domain of ERKs via a kinase interaction domain (KIM) located within the amino-terminal noncatalytic domain of the protein (14) (15) (16) . The latter domain also carries a functional leucine-rich nuclear export signal (NES), which mediates the cytoplasmic localisation of the protein (17) . DUSP6/MKP-3 is a transcriptional target of ERK itself and acts as a negative feedback regulator of pathway activity (18) .
Once induced in response to ERK activation, DUSP6/MKP-3 would be expected to bind to, dephosphorylate and retain ERK in the cytoplasm. Indeed, overexpression experiments have confirmed the ability of DUSP6/MKP-3 to act in this way to anchor ERKs in the cytosol: this anchoring function requires both a functional KIM and NES within the DUSP6/MKP-3 protein (17, 19) . In contrast to DUSP6/MKP-3, DUSP5 is an inducible nuclear ERK-specific MKP, which is also transcriptionally regulated by ERK signalling and has been proposed to act as a nuclear anchor for ERK (20, 21) . Again, overexpression experiments confirm the ability of DUSP5 to anchor inactive ERK within the cell nucleus and this is also dependent on the integrity of both the KIM and a nuclear localisation signal (NLS) located within the amino terminal domain of DUSP5 (20) .
In order to study the precise role of DUSP5 in regulating ERK activation and function, we recently generated mice in which the DUSP5 gene was deleted. These animals and cells derived from them were then used to ask two key questions about the role of DUSP5. Firstly, is ERK signalling deregulated in the absence of DUSP5, if so how does this affect the distribution of ERK/phospho-ERK and what biological endpoints are affected? Secondly, does DUSP5 play a role in modulating the oncogenic potential of mutant Ras oncogenes in vivo? To address the latter, we used the DMBA/TPA 4 model of skin carcinogenesis and found that loss of one or both copies of DUSP5 greatly sensitised mice to the development of skin papillomas. At the cellular level, we were able to show that loss of DUSP5 caused increased levels of nuclear phospho-ERK and gene expression studies identified a small cohort of ERK-dependent transcripts that were upregulated in cell lacking DUSP5. Prominent amongst the latter was SerpinB2, a protease inhibitor previously linked to susceptibility to DMBA/TPA-induced carcinogenesis. Surprisingly, deletion of serpinB2 completely reversed the sensitivity of mice lacking DUSP5 to DMBA/TPA indicating that DUSP5 acts as a tumour suppressor in this model by regulating nuclear ERK signalling and supressing the ERK-dependent expression of serpinB2 (22) .
In order to study the precise spatiotemporal regulation of ERK activation in murine cells lacking DUSP5, we made extensive use of quantitative high-content microscopy to detect the subcellular distribution of endogenous total ERK and phosphorylated, activated ERK over time, either after stimulation with phorbol ester or expression of mutant Hras. This technique uses automated fluorescence microscopy to analyse thousands of individual cells per condition, thus allowing an accurate quantitation of the spatiotemporal regulation of ERK activation in cell populations (23) . To link this regulation to the biochemical activities and ERK-binding properties of DUSP5 itself, we also employed adenoviral vectors expressing either wild type or mutant forms of DUSP5 under the control of the early growth response-1 (EGR-1) promoter. This allowed us to perform rescue experiments in which ERK-dependent DUSP5 expression was recapitulated in DUSP5 knockout cells at physiologically relevant levels. This differs from previous approaches, principally utilising DUSP5 overexpression under the control of constitutive promoters whose activity is divorced from ERK regulation, which do not reveal the same dynamic functions of DUSP5 as a feedback regulator. These techniques, together with more conventional biochemical fractionation methods to study the distribution of activated ERK are described in detail below and should be broadly applicable to the study of other MKPs which act to regulate ERK signalling such as DUSP1/MKP-2, DUSP2, DUSP4/MKP-2 and DUSP6/MKP-3. 13. DyLight™ 680 Conjugate, Goat anti-rabbit IgG (H+L) secondary antibody (Cell Signaling).
Materials

Methods
We have previously described methodology for sensitive detection of ERK and phosphorylated ERK in HeLa cells using high content microscopy (23) . Here, we describe similar approaches for studying ERK regulation by DUSP5 in primary MEFs by DUSP5 knockout and reconstitution using adenoviral (Ad) expression of Myc-tagged DUSP5, or mutants of DUSP5. An additional layer of complexity is added by the heterogeneity in cell shape and size in the non-monoclonal population, which presents new challenges for automated analysis. High quality monoclonal antibodies are available, which specifically recognise dual phosphorylated ERK1/2 (but neither mono-phosphorylated form), ERK1/2 (irrespective of phosphorylation state) and the Myc epitope tag, which are validated for use in immunofluorescence imaging and flow cytometry. The use of high-content microscopy and analysis is well suited to studying spatiotemporal aspects of DUSP5-ERK regulation, which requires quantitative assessment of ERK phosphorylation and subcellular distribution in multiple knockout rescue and stimulus conditions in parallel. Antibody detection allows multiplexed single cell assessment of p-ERK1/2, ERK1/2 and Myc 8 intensity and distribution in the same samples, as suitable antibodies for detection are available as mouse or rabbit monoclonals. Our microscopy results were cross-validated using immunoblotting of biochemically fractionated cell lysates, thus we have also included the methodology for this complementary approach here.
Generation of Recombinant Adenovirus
This method is based on the Iowa Gene Transfer Vector Core 'RapAd TM ' system (24) . All plasmids may be will cause lysis of the HEK293 flask within 24-72 h, and no effect should be seen on cell viability in either control flask. Harvest this lysate in a 50 ml tube as above. Snap-freeze the lysate in liquid N 2 and store at -80 o C for future large-scale amplification.
Large-scale amplification and purification of recombinant adenovirus
Amplification of adenovirus 1. Grow 10 x T175 flasks of low passage (<50) HEK293 cells to 60% confluency. To achieve 60%
confluency, split 1 x T175 flask into 10 x T175 flasks. Cells will be 60% confluent 1-2 days postsplit. 7. Resuspend the cell pellets and pool them in a total volume of 3 ml 100 mM Tris-HCl, pH 7.5.
8. Snap-freeze in liquid N 2 and store at -80 o C until ready for purification.
Purification of adenovirus
9. Thaw the harvested virus and cells (3 ml) on ice. This process can be accelerated using a 37 o C
waterbath, but it is important the mix does not warm to more than 4 o C. Snap-freeze in liquid N 2 and thaw (repeat process again a further 3 times to lyse cells).
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10. Centrifuge at 3000g for 10 min at 4 o C to remove cell debris.
11. Transfer the supernatant to an ultracentrifuge tube using a 5 ml syringe and 21G needle 12. Add 0.6 volumes of CsCl-saturated 100 mM Tris-HCl (prepare by adding CsCl to 100 mM TrisHCl, pH 7.5 until salt precipitates and no longer enters solution).
13. Fill the tube(s) with 1 volume 100 mM Tris : 0.6 volumes CsCl-saturated 100 mM Tris.
14. Balance tubes to within 0.01 g of each other.
15. Close the tubes using a heat sealer.
16. Add balance caps to the tubes and place tubes in rotor. Coat the rotor screw-tops with 'Spinkote' lubricant and screw on.
17. Close the caps to 120 psi using a torque wrench.
18. Centrifuge at 65,000 rpm for 6-8 h.
19. Remove tubes from rotor using tweezers.
20. Place in a stand in such a position to ensure that the viral band will be visible. Insert 2 x 25G needles into the top of the tube to equalise the pressure.
21. Remove the white viral particle band with a 19-21G needle and a 5 ml syringe. Insert the needle just below the viral band, taking care only to puncture one side of the tube, slowly insert the needle and then angle the needle upwards into the viral particle band. Slowly remove the viral particles using the syringe plunger.
22. Transfer the viral particles into a fresh ultracentrifuge tube and fill with 1 volume 100 mM Tris :
0.6 volumes CsCl-saturated 100 mM Tris.
23. Balance, heat seal, place in rotor as above and centrifuge for a second time overnight.
24. Remove the virus particle band as above, and inject into a 'Slide-a-Lyser' dialysis cassette.
Remove air from the cassette to allow maximal use of membrane surface area and efficient dialysis. Mark the entry point used for injection of the viral particles into the cassette, as the same one should not be used twice. 13. Add 100 µl/well of 300 nM DAPI diluted in PBS. Store at 4 o C until ready to image.
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High content microscopy and analysis
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These procedures are optimised for use with the GE Healthcare IN Cell Analyzer 2000 fluorescence microscope and proprietary "IN Cell" Investigator software. However, the same outcomes are achievable using most platforms. A schematic overview of the workflow involved in performing the analysis is given in Figure 1 and representative images and quantitative data are shown in Figure 2B 1. Plates must firstly be equilibrated to room temperature prior to imaging. This prevents condensation forming on the bottom of the plate and plate expansion during the run, which affect image consistency and quality.
2. In the microscope software 'acquisition mode' set-up, be sure to select the Costar plate type 3904 from the list of options (or alternative if a different culture plate is being used). If the plate is not in the database, then the plate dimensions will need to be added using the 'plate manager' button in the drop-down menu (see Note 7).
3. Dock the plate into the microscope, using the 'insert/eject plate' button in the toolbar ensuring that well A1 is in the top left-hand corner of the plate-holder tray. 8. Once the acquisition protocol is set up, it is not usually changed between assays, apart from to redefine the 'auto-offset' at the start of each session.
9. Acquire images by pressing the 'run protocol' button in the toolbar. Specify the file-path for the images (usually a server mapped to the computer) and type in an appropriate name for the experiment. Images will be directly saved to the server.
10. Once images are saved, proceed to image analysis. Note that this does not require the microscopejust a computer with access to the images. Open IN Cell Investigator software (or equivalent, such as 'Cell Profiler'). We use a bespoke analysis protocol for our staining procedure, so we include our settings merely as a guide. 14. Create 'Target linking-one to one linking' between 'Nuclei' and 'Cells' target sets using 90% overlap of 'Nuclei' within 'Cells' as acceptable, defining the linked objects as 'Nuclei_Cells'.
15. If necessary, apply a flat field correction to acquired images in the Alexa 488 and 546 channels (p-ERK1/2 and either ERK1/2 or Myc images, respectively), using 'Shading removal-QSM' and an offset value of 30-50 in multiplicative mode. 4. Continue to use the NE-PER nuclear and cytoplasmic extraction reagents (ThermoScientific) to isolate the cytoplasmic and nuclear fractions according to the manufacturer's instructions. Utilise the minimum reagent volumes recommended to obtain concentrated protein samples in the cellular fractions.
5. Perform a Bradford assay on the isolated cellular fractions to determine protein concentrations.
The cytoplasmic fraction is usually 3-4 times more concentrated than the nuclear fraction.
Normalise the protein concentrations within the samples and add NuPAGE LDS sample buffer (ThermoScientific) and boil at 95°C for 5 min.
6. Resolve equivalent quantities of protein by SDS-PAGE using NuPAGE® Novex® 4-12% gradient 4-12% Bis-Tris protein gels, transfer onto Immobilon-FL PVDF membranes, and block in 5% milk for 30 min at room temperature on a rocking platform. hyperchlorite or other peroxygen-based commercial disinfectant, such as 2% Virkon (Fisher Scientific).
7. Plate dimensions are usually available from the plate manufacturer, but an actual measure of plate thickness and skirt height can also be obtained using the 'laser autofocus trace' tool.
8. The '2x2 binning' function increases sensitivity and decreases image file size from 8Mb to 2Mb but reduces image resolution. We have shown this does not influence the quality of data gathering from cells the size of MEFs acquired using a 10x lens and measuring fluorescence changes in nuclear and cytoplasmic compartments, and actually improves signal/noise ratios.
9. The same outcomes are achievable using a range of commercially available subcellular fractionation kits and reagents and standard (ECL) immunoblotting procedures. show the increase in nuclear p-ERK, which results from deletion of DUSP5, but also reveal the role of
